IC
AEMD icon

Ikarian Capital’s Aethlon Medical AEMD Stock Holding History

Ikarian Capital’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.5K Hold
2,873
– – ﹤0.01% 157
2025
Q4 		$39.8K Sell
2,873
-200
-7% -$4.65K ﹤0.01% 167
2025
Q3 		$115K Hold
3,073
– – 0.01% 162
2025
Q2 		$184K Hold
3,073
– – 0.04% 115
2025
Q1 		$440K Buy
3,073
+1,198
+64% +$279K 0.05% 120
2024
Q4 		$645K Buy
+1,875
New +$318K 0.09% 124

Other funds holding AEMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ikarian Capital's AEMD Position: Q1 2026 in Review

Ikarian Capital held its Aethlon Medical (AEMD) position steady in Q1 2026 at 2,873 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Ikarian Capital first reported a position in AEMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $645K in Q4 2024. 11 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.

  • Ikarian Capital held 2,873 shares of Aethlon Medical worth $31.5K as of Q1 2026.
  • Ikarian Capital left its Aethlon Medical share count unchanged in Q1 2026.
  • Aethlon Medical made up ﹤0.01% of Ikarian Capital's portfolio in Q1 2026, its #157 holding.
  • Ikarian Capital first reported a position in Aethlon Medical in Q4 2024 and has held it in 6 quarters since.
  • Ikarian Capital's Aethlon Medical position peaked at $645K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.